Your browser doesn't support javascript.
loading
Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.
Kim, Byung Jin; Cha, Kwang Soo; Cho, Wook Hyun; Kim, Eung Ju; Choi, Seung-Hyuk; Kim, Moo Hyun; Kim, Sang-Hyun; Park, Jun-Bean; Park, Seong-Mi; Sohn, Il Suk; Ryu, Kyu Hyung; Chae, In-Ho.
Afiliação
  • Kim BJ; Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Cha KS; Department of Internal Medicine and Medial Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.
  • Cho WH; Department of Cardiology, Sahmyook Medical Center, Seoul, Republic of Korea.
  • Kim EJ; Department of Cardiology, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Choi SH; Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim MH; Department of Cardiology, Dong-A University Medical Center, Busan, Republic of Korea.
  • Kim SH; Department of Cardiology, Boramae Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park JB; Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park SM; Division of Cardiology, Department of Internal Medicine, Korea University Medicine, Anam Hospital, Seoul, Republic of Korea.
  • Sohn IS; Department of Cardiology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
  • Ryu KH; Department of Cardiology, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, Republic of Korea.
  • Chae IH; Department of Internal Medicine, Seoul National University, Bundang Hospital, Gyeonggi-do, Republic of Korea.
J Cardiovasc Pharmacol Ther ; 28: 10742484231205204, 2023.
Article em En | MEDLINE | ID: mdl-37814541
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article